A million potential missed cancer screenings with new Medicaid restrictions, study finds

Also: Parabilis Medicine raises $305 million as CEO warms to an IPO

January 9, 2026 Check out STAT+

Sponsored By

A CDC group charged with developing vaccine recommendations? Solve STAT's latest mini-crossword.

ASHRAF SHAZLY/AFP via Getty Images Medicaid restrictions may lead to a million missed cancer screenings over two years: study New Medicaid eligibility rules may cause more than a million missed cancer screenings, and more than 100 preventable deaths, new study says. By Angus Chen STAT+ | Parabilis Medicines raises $305 million as CEO warms to an IPO The company, formerly known as FogPharma, is the latest biotech firm to attract crossover investors. By Allison DeAngelis Women are celebrating at-home cervical cancer screening, but might it lead them to get fewer checkups? New federal guidelines let most women screen for cervical cancer at home using HPV tests, reducing pelvic exams while raising care questions By Annalisa Merelli

More around STAT

---

In case you missed it Merck in talks to buy cancer drugmaker Revolution Medicines for up to $32B, Financial Times The war over Roundup weedkiller might be headed to the Supreme Court, New York Times "We just sit and cry": Gaza's cancer patients die waiting for treatment, Al Jazeera

---

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2026, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser